Penn Medicine Provider
Hematology, Medical Oncology
Meher Burki, MD
4.9
(660)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Kennett Square
View 2 additional locations
Make an appointmentCall 800-789-7366

About me

  • Director, Breast Program, Chester County Hospital
  • Co-Chair, Breast Program Leadership Committee, Chester County Hospital

Education and training

  • Medical School: Aga Khan University Medical College
  • Residency: Temple University Hospital
  • Fellowship: Fox Chase Cancer Center

What my patients think about me

Average Rating
4.9

662 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
she is excellent
May 2025
5.0
5.0
very accommodating
May 2025
5.0
5.0
felt she was working on my behalf. making sure i was getting what i needed to move forward.
May 2025
5.0
5.0
provider was very nice, professional and knowledgeable. she answered all of my questions

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Burki is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Shaikh T, Burki M, Wang LS, Egleston B, Hoffman JP, Cohen SJ, Meyer JE. Identifying factors impacting subsequent gemcitabine dose intensity in patients undergoing chemoradiation for locally advanced pancreatic cancer. , ASCO Gastrointestinal Cancers Symposium: 2015

Shaikh T, Burki M, Egleston BL, Wang L, Cohen SJ, Meyer JE. Defining The Optimal Sequencing of Chemotherapy (Cx) and Radiation (RT)in Patients (pts) with locally advanced Pancreatic Cancer , ASTRO Annual Meeting: 2014

Skarbnik AP, Burki M, Pro B. Peripheral T-cell lymphomas: a review of current approaches and hopes for the future. , Frontiers in oncology, 3: 2013,138

Alkhouli M, Burki M, Ward L. Myxedema Coma Complicated by Herpes Encephalitis. , Regional SGIM: 2010

Burki M, Telivala B, George G, Gupta A, Padmanabhan S, Ali A. Impact of Race on Survival Outcomes in Metastatic Non-Small Cell Lung Cancer , Temple University School of Medicine Research Symposia: 2009

Usmani S, Bhaila I, Burki M, Farook M, Siddiqi H, Sophie M. Middle Aged Woman with Acute Onset Chest Pain. , Temple University School of Medicine's Sol Sherry Honor Society: 2009

Usmani S, Bhaila I, Burki M, Farook M, Siddiqi H, Sophie, M. Awareness, Attitudes and Understanding Regarding Epilepsy in the People Presenting to a Tertiary Care Hospital. , Community Health Center - Aga Khan University: 2004

Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q 13.3 is not associated with asthma and atopy in three independent populations. , Clinical and , 5(34): 2004,736-744

Munoz M, Zambelli-Weiner A, Grant A, Lorenzo M, Ehrlich E, Burki M, Li Gao L, Ye S, Beaty TH, Garcia JGN, Barnes KC. Association between a variant in the gene encoding myosin light chain kinase (MLCK) and asthma and atopy. , Journal of Allergy and Clinical Immunology., 2(113): 2004,S206

Burki M. Association Between A Varient in the Gene Encoding MLCK and Asthma and Allergy , Presented Research work in departmental rounds at the Asthma and Allergy Center at John Hopkins University: 2003